Aggregation of amyloid beta into amyloid plaques in the brain is a hallmark characteristic of
Alzheimer's disease. Therapeutics aimed at preventing or retarding amyloid formation often …

Fibril formation of the amyloid-β peptide (Aβ) follows a nucleation-dependent polymerization
process and is associated with Alzheimer's disease. Several different lengths of Aβ are …

The formation and analysis of amyloid fibers by two β-glucosidases, BglA and BglB,
belonging to the GH1 enzyme family, are reported. Both proteins have the (β/α) 8 TIM-barrel …

Metal chelates targeted to amyloid peptides are widely explored as diagnostic tools or
therapeutic agents. The attachment of a metal complex to amyloid recognition units typically …

A β amyloid fibrils have been demonstrated to be vital for triggering Alzheimer's disease, as
reported by numerous research works. Therefore, A β amyloid fibrils formation is considered …

A defective protein folding and its abnormal aggregation and accumulation is the central
pathogenic event in Protein Conformational diseases (PCDs), such as Alzheimers Disease …

A defective protein folding and its abnormal aggregation and accumulation is the central
pathogenic event in Protein Conformational diseases (PCDs), such as Alzheimers Disease …